Pharmaceutical compositions for the treatment and/or...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/496 (2006.01) A61K 31/137 (2006.01) A61K 31/138 (2006.01) A61K 31/343 (2006.01) A61K 31/381 (2006.01) A61P 25/24 (2006.01)

Patent

CA 2599721

The invention relates to new pharmaceutical compositions for the treatment and/or prevention of depression and methods for the preparation thereof. In a preferred embodiment, the instant invention is directed to pharmaceutical combinations comprising flibanserin as one active ingredient in combination with at least one additional active ingredient for the treatment and/or prevention of depression and methods for the preparation thereof.

L'invention porte sur de nouvelles compositions pharmaceutiques utiles dans le traitement et/ou la prévention de la dépression et sur leurs procédés de préparation. Selon une forme d'exécution préférée, l'invention porte sur des combinaisons pharmaceutiques comprenant la flibanserine comme ingrédient actif en combinaison avec au moins un ingrédient actif additionnel, ces combinaisons pharmaceutiques étant utiles dans le traitement et/ou la prévention de la dépression. L'invention porte également sur les procédés de préparation de ces combinaisons pharmaceutiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical compositions for the treatment and/or... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions for the treatment and/or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions for the treatment and/or... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1889489

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.